Cargando…

Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein

The aggregation of alpha-synuclein (α-SYN) follows a cascade of oligomeric, prefibrillar and fibrillar forms, culminating in the formation of Lewy Bodies (LB), the pathological hallmarks of Parkinson’s Disease. Although LB contain over 70 proteins, the potential for interactions along the aggregatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Leitão, André D. G., Rudolffi-Soto, Paulina, Chappard, Alexandre, Bhumkar, Akshay, Lau, Derrick, Hunter, Dominic J. B., Gambin, Yann, Sierecki, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460662/
https://www.ncbi.nlm.nih.gov/pubmed/34556785
http://dx.doi.org/10.1038/s42003-021-02624-x
_version_ 1784571803036811264
author Leitão, André D. G.
Rudolffi-Soto, Paulina
Chappard, Alexandre
Bhumkar, Akshay
Lau, Derrick
Hunter, Dominic J. B.
Gambin, Yann
Sierecki, Emma
author_facet Leitão, André D. G.
Rudolffi-Soto, Paulina
Chappard, Alexandre
Bhumkar, Akshay
Lau, Derrick
Hunter, Dominic J. B.
Gambin, Yann
Sierecki, Emma
author_sort Leitão, André D. G.
collection PubMed
description The aggregation of alpha-synuclein (α-SYN) follows a cascade of oligomeric, prefibrillar and fibrillar forms, culminating in the formation of Lewy Bodies (LB), the pathological hallmarks of Parkinson’s Disease. Although LB contain over 70 proteins, the potential for interactions along the aggregation pathway of α-SYN is unknown. Here we propose a map of interactions of 65 proteins against different species of α-SYN. We measured binding to monomeric α-SYN using AlphaScreen, a sensitive nano-bead luminescence assay for detection of protein interactions. To access oligomeric species, we used the pathological mutants of α-SYN (A30P, G51D and A53T) which form oligomers with distinct properties. Finally, we generated amyloid fibrils from recombinant α-SYN. Binding to oligomers and fibrils was measured by two-color coincidence detection (TCCD) on a single molecule spectroscopy setup. Overall, we demonstrate that LB components are recruited to specific steps in the aggregation of α-SYN, uncovering future targets to modulate aggregation in synucleinopathies.
format Online
Article
Text
id pubmed-8460662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84606622021-10-22 Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein Leitão, André D. G. Rudolffi-Soto, Paulina Chappard, Alexandre Bhumkar, Akshay Lau, Derrick Hunter, Dominic J. B. Gambin, Yann Sierecki, Emma Commun Biol Article The aggregation of alpha-synuclein (α-SYN) follows a cascade of oligomeric, prefibrillar and fibrillar forms, culminating in the formation of Lewy Bodies (LB), the pathological hallmarks of Parkinson’s Disease. Although LB contain over 70 proteins, the potential for interactions along the aggregation pathway of α-SYN is unknown. Here we propose a map of interactions of 65 proteins against different species of α-SYN. We measured binding to monomeric α-SYN using AlphaScreen, a sensitive nano-bead luminescence assay for detection of protein interactions. To access oligomeric species, we used the pathological mutants of α-SYN (A30P, G51D and A53T) which form oligomers with distinct properties. Finally, we generated amyloid fibrils from recombinant α-SYN. Binding to oligomers and fibrils was measured by two-color coincidence detection (TCCD) on a single molecule spectroscopy setup. Overall, we demonstrate that LB components are recruited to specific steps in the aggregation of α-SYN, uncovering future targets to modulate aggregation in synucleinopathies. Nature Publishing Group UK 2021-09-23 /pmc/articles/PMC8460662/ /pubmed/34556785 http://dx.doi.org/10.1038/s42003-021-02624-x Text en © Crown 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Leitão, André D. G.
Rudolffi-Soto, Paulina
Chappard, Alexandre
Bhumkar, Akshay
Lau, Derrick
Hunter, Dominic J. B.
Gambin, Yann
Sierecki, Emma
Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
title Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
title_full Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
title_fullStr Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
title_full_unstemmed Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
title_short Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
title_sort selectivity of lewy body protein interactions along the aggregation pathway of α-synuclein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460662/
https://www.ncbi.nlm.nih.gov/pubmed/34556785
http://dx.doi.org/10.1038/s42003-021-02624-x
work_keys_str_mv AT leitaoandredg selectivityoflewybodyproteininteractionsalongtheaggregationpathwayofasynuclein
AT rudolffisotopaulina selectivityoflewybodyproteininteractionsalongtheaggregationpathwayofasynuclein
AT chappardalexandre selectivityoflewybodyproteininteractionsalongtheaggregationpathwayofasynuclein
AT bhumkarakshay selectivityoflewybodyproteininteractionsalongtheaggregationpathwayofasynuclein
AT lauderrick selectivityoflewybodyproteininteractionsalongtheaggregationpathwayofasynuclein
AT hunterdominicjb selectivityoflewybodyproteininteractionsalongtheaggregationpathwayofasynuclein
AT gambinyann selectivityoflewybodyproteininteractionsalongtheaggregationpathwayofasynuclein
AT siereckiemma selectivityoflewybodyproteininteractionsalongtheaggregationpathwayofasynuclein